CVS Health (CVS)
(Delayed Data from NYSE)
$78.15 USD
+1.46 (1.90%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $78.00 -0.15 (-0.19%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Key Expected Earnings Data
| Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
|---|---|---|---|
| 02/11/2026
Time: -- |
12/2025 | $0.95 | 0.23% |
Earnings Summary
For their last quarter, CVS Health (CVS) reported earnings of $1.60 per share, beating the Zacks Consensus Estimate of $1.36 per share. This reflects a positive earnings surprise of 17.65%. Look out for CVS's next earnings release expected on February 11, 2026. For the next earning release, we expect the company to report earnings of $0.95 per share, reflecting a year-over-year decrease of 20.17%.
Earnings History
Price & Consensus
Zacks News for CVS
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?
CVS vs. FMS: Which Healthcare Services Stock Has More Upside?
CVS FAQs
CVS Health Corporation (CVS) has announced they will report their next quarter earnings on February 11, 2026. For the next earning release, we expect the company to report earnings of $0.95 per share, reflecting a year-over-year decrease of -20.17%.
CVS Health Corporation has announced they will report their previous quarter earnings after the close of the market on February 11, 2026.
The Zacks Consensus Estimate for CVS Health Corporation (CVS) for the quarter ending in December 2025 is $0.95 a share. We expect CVS Health Corporation to miss by 0.23%.
In the earnings report for the quarter ending in June 2024, CVS Health Corporation (CVS) announced earnings of $1.83 per share versus the Zacks Consensus Estimate of $1.74 per share, representing a surprise of 5.17%.
